Medical Xpress news
Medical Xpress / Quitting GLP-1 drugs triggers rapid regain, but 25% of weight loss may last
A year after stopping taking weight-loss drugs such as Ozempic and Wegovy, people regain—on average—60% of their lost weight. But beyond this, their regained weight plateaus, with individuals managing to keep off 25% ...
Medical Xpress / Eye tracking and brain signals reveal how some skills become second nature
Expertise isn't easy to pass down. Take riding a bike: A seasoned cyclist might talk a beginner through the basics of how to sit and when to push off. But other skills, like how hard to pedal to keep balanced, are more intuitive ...
Medical Xpress / GLP-1 medications get at the heart of addiction, study finds
Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be effective at treating and preventing substance-use disorders across all major addictive substances ...
Medical Xpress / Psychedelics may aid PTSD recovery by repairing brain myelin, study finds
Post-traumatic stress disorder (PTSD) is not only characterized by strongly encoded traumatic memories, but also by disrupted coordination across brain networks. New research shows that treatment with psychedelic drugs triggers ...
Medical Xpress / Time changes still frustrate Americans, and the fall shift appears to linger longer
Individuals have a more negative reaction to the societal time change to Standard Time (ST) in the fall than to Daylight Saving Time (DST) in the spring, according to a study published in the open-access journal PLOS One. ...
Medical Xpress / High-dose folic acid prevents diabetic peripheral neuropathy in mice, study finds
Florida State University researchers have demonstrated that significantly increasing dietary folic acid in mice can prevent peripheral neuropathy, a condition commonly associated with diabetes and other health issues. The ...
Medical Xpress / Why some tiny tumors vanish and others grow: Discovery could help treat cancer at very earliest stages
Cambridge scientists have shown that when tumors first emerge, interactions with healthy cells in the underlying supportive tissue determine their ability to survive, grow, and progress to advanced stages of disease.
Medical Xpress / First gene regulation clinical trials for epilepsy show promising results
A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that the first gene regulation treatment for epilepsy is safe and well tolerated by patients with Dravet ...
Medical Xpress / Stem cells from human baby teeth show promise for treating cerebral palsy
A Japanese research team has demonstrated in rat experiments that stem cells from human primary tooth pulp may help treat chronic-phase cerebral palsy. "This is the first animal study to show that stem cell treatment works ...
Medical Xpress / AI could help predict your risk of breast cancer in the next four years
An artificial intelligence (AI) algorithm used to detect breast cancer in screening scans has been adapted into a risk score that estimates a woman's risk of developing breast cancer over the next four years, according to ...
Medical Xpress / Engineered CAR-T cells block key protein to break solid tumors' immune shield
UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor microenvironment, a protective shield that tumors use to weaken immune cells, block their attack, and fuel ...
Medical Xpress / Microbe fragments 'train' lungs to resist allergies for months, study finds
A study conducted by scientists from the Institut Pasteur has revealed that microbes protect the lungs from subsequently developing allergies and asthma. This long-term protection is "memorized" not by immune system cells, ...